Copyright
©2013 Baishideng Publishing Group Co.
World J Gastrointest Endosc. May 16, 2013; 5(5): 231-239
Published online May 16, 2013. doi: 10.4253/wjge.v5.i5.231
Published online May 16, 2013. doi: 10.4253/wjge.v5.i5.231
Lidocaine | Placebo | Diff1 | P2 | ||
Age, yr | |||||
< 65 | |||||
Total propofol dose | 338.1 ± 138.7 | 292.0 ± 90.3 | 46.1 (-2.2, 94.4) | 0.06 | |
Partial3 propofol dose | 147.2 ± 165.6 | 128.9 ± 96.5 | 18.3 (-37.7, 74.3) | 0.51 | |
> 65 | |||||
Total propofol dose | 203.6 ± 77.8 | 241.1 ± 68.0 | -37.5 (-96.5, 21.5) | 0.20 | |
Partial propofol dose | 88.7 ± 61.6 | 102.3 ± 97.1 | -13.6 (-80.8, 53.6) | 0.67 | |
Sex | |||||
Male | |||||
Total propofol dose | 280.0 ± 101.3 | 246.7 ± 69.6 | 33.3 (-19.2, 85.8) | 0.20 | |
Partial propofol dose | 97.3 ± 95.5 | 125.0 ± 108.0 | -27.7 (-33.7, 89.1) | 0.36 | |
Female | |||||
Total propofol dose | 330.4 ± 157.0 | 299.6 ± 92.1 | 30.8 (-28.5, 90.0) | 0.30 | |
Partial propofol dose | 141.9 ± 175.2 | 137.5 ± 95.2 | 4.4 (-60.5, 69.3) | 0.89 | |
ASA classification | |||||
I-II | |||||
Total propofol dose | 336.5 ± 141.2 | 284.6 ± 91.2 | 51.9 (2.8, 100.9) | 0.03 | |
Partial propofol dose | 149.6 ± 164.5 | 122.1 ± 99.6 | 27.5 (-28.6, 83.6) | 0.16 | |
III-IV | |||||
Total propofol dose | 209.7 ± 70.0 | 265.7 ± 76.7 | 56.0 (-3.8, 115.8) | 0.06 | |
Partial propofol dose | 79.4 ± 63.3 | 125.0 ± 88.9 | -45.6 (-19.3, 110.5) | 0.16 | |
Mallampati classification | |||||
I-II | |||||
Total propofol dose | 319.6 ± 140.0 | 284.3 ± 91.4 | 35.4 (-12.2, 83.0) | 0.14 | |
Partial propofol dose | 136.1 ± 159.2 | 117.7 ± 102.1 | 18.4 (-35.4, 72.2) | 0.49 | |
III-IV | |||||
Total propofol dose | 260.8 ± 130.7 | 263.6 ± 72.3 | -2.8 (-96.0, 90.5) | 0.95 | |
Partial propofol dose | 130.8 ± 108.0 | 142.8 ± 69.9 | -12.0 (-93.2, 69.2) | 0.76 | |
Drug abuse | |||||
Yes | |||||
Total propofol dose | 313.5 ± 115.2 | 327.6 ± 75.4 | -14.1 (-156.1, 127.9) | 0.82 | |
Partial propofol dose | 96.1 ± 100.8 | 144.4 ± 73.8 | -48.3 (-177.1, 80.5) | 0.41 | |
No | |||||
Total propofol dose | 310.5 ± 142.2 | 275.9 ± 88.2 | 34.6 (-10.2, 79.4) | 0.12 | |
Partial propofol dose | 138.9 ± 155.1 | 120.8 ± 98.6 | 18.1 (-31.1, 67.3) | 0.46 | |
Previous sedated EGD | |||||
Yes | |||||
Total propofol dose | 297.6 ± 116.3 | 226.1 ± 79.1 | 71.6 (-18.4, 161.7) | 0.11 | |
Partial propofol dose | 124.4 ± 129.5 | 132.9 ± 91.5 | -8.5 (-110.1, 93.1) | 0.86 | |
No | |||||
Total propofol dose | 313.4 ± 144.4 | 292.3 ± 85.7 | 21.1 (-26.9, 69.1) | 0.38 | |
Partial propofol dose | 137.5 ± 157.0 | 120.4 ± 98.4 | 17.1 (-35.8, 70.0) | 0.52 |
- Citation: de la Morena F, Santander C, Esteban C, de Cuenca B, García JA, Sánchez J, Moreno R. Usefulness of applying lidocaine in esophagogastroduodenoscopy performed under sedation with propofol. World J Gastrointest Endosc 2013; 5(5): 231-239
- URL: https://www.wjgnet.com/1948-5190/full/v5/i5/231.htm
- DOI: https://dx.doi.org/10.4253/wjge.v5.i5.231